8-K filing — Century Therapeutics, Inc. (IPSC)
Filed: 2026-10-02 AccNo: 0001104659-26-113055 Size: 4 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Century Therapeutics Presents CNTY-813 Nonclinical Data At EASD 2026
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Century Therapeutics Q2 EPS $(0.17) Misses $(0.14) Estimate
Century Therapeutics (NASDAQ:IPSC) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 55.26 percent increase over losses of $(0.38) per